Unravel Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Unravel Biosciences, Inc. - overview
Established
2021
Location
Boston, MA-Massachusetts, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2021, Unravel Biosciences, Inc. facilitates target agnostic therapeutics discovery. The company was co-founded by Richard Novak (CEO) and Frederic Vigneault. In July 2021, the firm raised an amount of USD 0.
5 million in Seed funding from investor RTK Group. The company offers BioNAV™ platform that combines drug discovery, patient stratification, and preclinical screening to find treatments for complex diseases impacting the whole body. It has created an advanced, impartial technology that combines in vivo disease model screening with ground-truth patient RNA data to find and eliminate potential risks from new treatment targets for even the most complicated diseases. The firm service range includes patient RNAseq, patient stratification, drug repurposing, and clinical translation.
Current Investors
RTK Group
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.unravel.bio
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Unravel Biosciences, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Seed | Completed | Unravel Biosciences, Inc. | - |
Displaying 1 - 1 of 1
Unravel Biosciences, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.